Blueprint Medicines Corp (BPMC)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Aug 13, 16:00
Blueprint Medicines Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 13, 2025 | 24.43 |
| August 12, 2025 | 24.43 |
| August 11, 2025 | 24.43 |
| August 08, 2025 | 24.43 |
| August 07, 2025 | 24.43 |
| August 06, 2025 | 24.43 |
| August 05, 2025 | 24.43 |
| August 04, 2025 | 24.43 |
| August 01, 2025 | 24.43 |
| July 31, 2025 | 24.43 |
| July 30, 2025 | 24.43 |
| July 29, 2025 | 24.43 |
| July 28, 2025 | 24.43 |
| July 25, 2025 | 24.43 |
| July 24, 2025 | 24.43 |
| July 23, 2025 | 24.43 |
| July 22, 2025 | 24.43 |
| July 21, 2025 | 24.43 |
| July 18, 2025 | 24.43 |
| July 17, 2025 | 24.43 |
| July 16, 2025 | 24.40 |
| July 15, 2025 | 24.41 |
| July 14, 2025 | 24.41 |
| July 11, 2025 | 24.40 |
| July 10, 2025 | 24.41 |
| Date | Value |
|---|---|
| July 09, 2025 | 24.26 |
| July 08, 2025 | 24.23 |
| July 07, 2025 | 24.23 |
| July 03, 2025 | 24.22 |
| July 02, 2025 | 24.19 |
| July 01, 2025 | 24.22 |
| June 30, 2025 | 24.19 |
| June 27, 2025 | 24.18 |
| June 26, 2025 | 24.18 |
| June 25, 2025 | 24.20 |
| June 24, 2025 | 24.20 |
| June 23, 2025 | 24.23 |
| June 20, 2025 | 24.19 |
| June 18, 2025 | 24.18 |
| June 17, 2025 | 24.20 |
| June 16, 2025 | 24.20 |
| June 13, 2025 | 24.15 |
| June 12, 2025 | 24.19 |
| June 11, 2025 | 24.15 |
| June 10, 2025 | 24.15 |
| June 09, 2025 | 24.15 |
| June 06, 2025 | 24.13 |
| June 05, 2025 | 24.14 |
| June 04, 2025 | 24.17 |
| June 03, 2025 | 24.08 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.13 |
| Altimmune, Inc. | 1.359 |
| Amarantus Bioscience Holdings, Inc. | -- |
| Aligos Therapeutics, Inc. | 1.121 |
Price to Book Value Related Metrics
| Price | 129.46 |